Detalles de la búsqueda
1.
IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma.
Haematologica
; 2024 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38385243
2.
Real-world experience with decitabine as a first-line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy.
Hematol Oncol
; 37(4): 447-455, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31385337
3.
Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysis.
Support Care Cancer
; 24(11): 4487-93, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27260015
4.
Real-life diagnostic and therapeutic approach to CLL: a 2022 update from an expert panel in Tuscany.
Clin Exp Med
; 23(8): 4251-4264, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37979127
5.
Relapsed/Refractory Chronic Lymphocytic Leukemia Patients Treated with Fixed Duration Venetoclax-Rituximab: Assessment of Response with Ultrasound, and Relationship with Minimal Residual Disease.
J Clin Med
; 12(5)2023 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36902559
6.
Impact of different chemotherapy regimens on intestinal mucosal injury assessed with bedside ultrasound: a study in 213 AML patients.
Front Oncol
; 13: 1272072, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38023169
7.
A Prospective Cross-Sectional Study on the Comparison of Ultrasound Assessment vs. Palpation in Chronic Lymphocytic Leukemia Patients in the Era of Targeted Therapy.
J Clin Med
; 11(11)2022 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35683596
8.
Unusual presentation of extranodal diffuse large B-cell lymphoma in a solid-organ recipient during long-term immunosuppressive treatment.
Tumori
; 107(6): NP127-NP130, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34423702
9.
Perspectives and Emotional Experiences of Patients With Chronic Myeloid Leukemia During ENESTPath Clinical Trial and Treatment-Free Remission: Rationale and Protocol of the Italian Substudy.
Front Oncol
; 11: 638689, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34123791
10.
JAK Inhibition with Ruxolitinib in Patients with COVID-19 and Severe Pneumonia: Multicenter Clinical Experience from a Compassionate Use Program in Italy.
J Clin Med
; 10(16)2021 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34442045
11.
Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol.
Front Med (Lausanne)
; 7: 466, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32850921
12.
Chronic Myeloid Leukemia Patient's Voice About the Experience of Treatment-Free Remission Failure: Results From the Italian Sub-Study of ENESTPath Exploring the Emotional Experience of Patients During Different Phases of a Clinical Trial.
Front Psychol
; 10: 329, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30842749
13.
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19.
Leukemia
; 34(10): 2815-2816, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32879427
14.
Efficacy and safety of ruxolitinib for Covid-19 related acute respiratory distress syndrome in a patient with blastic plasmacytoid dendritic cell neoplasm (leukemic variant).
Leuk Lymphoma
; 61(14): 3523-3525, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32902339
15.
Heart involvement in T cell lymphoma through hypereosinophilic syndrome: a common complication of a rare condition.
J Cardiovasc Magn Reson
; 7(2): 495-9, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-15881534
Resultados
1 -
15
de 15
1
Próxima >
>>